Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Youbang Biological Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Jinyu Bio-technology, is a high-tech enterprise specializing in the research, development, production, and sales of veterinary biological products. Founded in 2004 and based in Yangzhou, China, the company operates six GMP-certified production lines for various types of vaccines, including embryo-derived and cell-derived inactivated and live vaccines. Its product portfolio primarily focuses on vaccines for swine, poultry, and waterfowl, with key products targeting porcine circovirus, Newcastle disease, and PRRS. The company leverages advanced technology platforms such as large-scale cell suspension culture and genetic engineering to develop next-generation veterinary vaccines. Yangzhou Youbang maintains strong academic collaborations with institutions like Yangzhou University and the Chinese Academy of Agricultural Sciences to drive innovation in animal disease prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Youbang Biological Pharmaceutical.